| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.55 | 0.05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |